Literature DB >> 3517536

Secondary dapsone-resistant leprosy in Brazil: a preliminary report.

M H dos Santos Damasco, S Talhari, S M Viana, M Signorelli, M H Saad, L M Andrade.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3517536     DOI： 10.5935/0305-7518.19860002

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  4 in total

1.  Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse.

Authors:  Adalgiza da Silva Rocha; Alexandre Araujo Cunha Dos Santos; Patrícia Pignataro; José Augusto Nery; Antônio Basílio de Miranda; Diego Fonseca Soares; Amanda Nogueira Brum Fontes; Alice Miranda; Helen Ferreira; Neio Boéchat; Maria Eugênia Novisck Gallo; Euzenir Nunes Sarno; Maria Leide W De Oliveira; Philip Noel Suffys
Journal:  J Med Microbiol       Date:  2011-05-19       Impact factor: 2.472

2.  Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients.

Authors:  Adalgiza da Silva Rocha; Maria das Graças Cunha; Lucia Martins Diniz; Claudio Salgado; Maria Araci P Aires; José Augusto Nery; Eugênia Novisck Gallo; Alice Miranda; Monica M F Magnanini; Masanori Matsuoka; Euzenir Nunes Sarno; Philip Noel Suffys; Maria Leide W de Oliveira
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

3.  Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.

Authors:  Elaine Silva Nascimento Andrade; Jurema Guerrieri Brandão; Juliana Souza da Silva; Carmelita Ribeiro Filha Coriolano; Patricia Sammarco Rosa; Milton Ozório Moraes; Cynthia de Oliveira Ferreira; Ciro Martins Gomes; Wildo Navegantes de Araújo
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

Review 4.  Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.

Authors:  Rossilene Conceição da Silva Cruz; Samira Bührer-Sékula; Maria Lúcia F Penna; Gerson Oliveira Penna; Sinésio Talhari
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.